“Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer”, AMAR, vol. 4, no. 3, pp. 985–1101, Mar. 2026, doi: 10.66021/.